Genetic Analysis of MEFV Gene Pyrin Domain in Patients With Behçet's Disease by Dursun, Ahmet et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2006, Article ID 41783, Pages 1–4
DOI 10.1155/MI/2006/41783
ResearchCommunication
Genetic Analysis of MEFV Gene Pyrin Domain in
Patients With Behc ¸et’s Disease
Ahmet Dursun,1 Hatice Gul Durakbasi-Dursun,2 Ayse Gul Zamani,2 Zerrin G¨ ulin Gulbahar,3
Recep Dursun,4 and Cengiz Yakicier3
1Department of Medical Genetics, Faculty of Medicine, Zonguldak Karaelmas University, 67600 Zonguldak, Turkey
2Department of Medical Genetics, Meram Medical Faculty, Selcuk University, 42080 Konya, Turkey
3Department of Molecular Biology and Genetics, Bilkent University, 06800 Ankara, Turkey
4Department of Dermatology, Baskent University, 42080 Konya, Turkey
Received 3 January 2006; Revised 20 January 2006; Accepted 20 January 2006
Objectives.B e h c ¸et’s disease (BD) is a systemic vasculitis with recurrent oral and genital ulcers and uveitis. MEFV gene, which is
the main factor in familial Mediterranean fever (FMF), is also reported to be a susceptibility gene for BD. The pyrin domain of
MEFV gene is a member of death-domain superfamily and has been proposed to regulate inﬂammatory signaling in myeloid cells.
This study was designed to determine if mutations in pyrin domain of MEFV gene are involved in BD. Methods. We analyzed the
pyrin domain of MEFV gene in 54 Turkish patients with BD by PCR-analysis and direct sequencing. Results. Neither deletion or
insertion mutations nor point mutations in pyrin domain were found in any patient. Conclusion. Although pyrin gene mutations
have been reported in patients with BD, pyrin domain is not mutated. However, alterations in other regions of MEFV gene and
interaction between pyrin domains are needed to be further investigated.
Copyright © 2006 Ahmet Dursun et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Behc ¸et’s disease (BD) is an unclassiﬁed systemic vasculitis
with a chronic course. Although it was originally described
with recurrent oral and genital ulcers and uveitis, it is now
recognized as a multisystem disorder also aﬀecting all types
and sizes of blood vessels, the joints, the central nervous sys-
tem, the lungs, and the intestines [1]. The pathogenesis of
BD is not known, however, it possibly involves complex in-
teractions of genetic and environmental factors. The mani-
festations of BD are considered to be developed as a result
of immunological dysfunction, which is suggested to be in-
duced by exogenic pathogens in genetically susceptible indi-
viduals and includes hyperreactivity of neutrophils, overex-
pressionofseveralproinﬂammatoryandTh1-typecytokines,
and several phenotypic and functional lymphocyte abnor-
malities [2, 3].
MEFV gene mutations have been reported to be respon-
sible for familial Mediterranean fever (FMF) which is an au-
tosomal recessive and is also known as an autoinﬂammatory
diseasethatischaracterizedbyrecurrentepisodesofunseem-
ingly unprovoked inﬂammation that, unlike autoimmune
disorders, lack the production of high-titer autoantibodies
or antigen-speciﬁc T cells [4]. MEFV gene has also been
suggested recently to be a susceptibility gene for BD [5, 6].
MEFV gene, was identiﬁed in 1997 by positional cloning [7]
encoding a 781-amino-acid protein, pyrin, which is predom-
inantly expressed in polymorphonuclear leukocytes (PMNs)
and cytokine-activated monocytes [8]. Pyrin consists of four
functional domains, a B-box zinc-ﬁnger domain, a coiled-
coil domain, a C-terminal B30.2 domain, and a 92-amino-
acid N-terminal pyrin domain that is shared by a number of
other proteins involved in apoptosis and inﬂammation [9].
The pyrin domain is a member of the six-helix bun-
dle, death-domain superfamily that includes death domains,
death eﬀector domains, and caspase recruitment domains
(CARDs) [10]. Although the function of pyrin protein re-
mains to be determined, it has been proposed to regulate in-
ﬂammatory signaling in myeloid cells [11]. It has been sug-
gestedthatpyrindomain,asanovelproteinmodule,isfound
in proteins that are thought to function in apoptotic and in-
ﬂammatory signaling pathways [11]. BD is not a Mendelian
disorder; however, considering its occasional familial presen-
tationanditscloseassociationwithgenesofmajorhistocom-
patibility complexes, BD is under some sort of genetic con-
trol [12]. As MEFV gene mutations were present in BD, this2 Mediators of Inﬂammation
study was designed to determine whether mutations of pyrin
domain of MEFV gene are related to BD and its inﬂamma-
tory process.
MATERIALS AND METHODS
A total of 54 Turkish patients with Behc ¸et’s disease were in-
cluded in this study. Patients with Behc ¸et’s disease were all
fulﬁlling at least three of the International Study Group [13]
criteria for BD and were clinically and serologically diag-
nosed by Department of Dermatology, Meram Medical Fac-
ulty, Selcuk University, 29 out of 54 patients were females.
PCR,sequencing,andmutationalanalysis
Speciﬁc primers for PCR ampliﬁcation (406bp) and se-
quencing of MEFV gene pyrin domain were designed us-
ing the Primer 3 program (PF: 5 -CAACCTGCCTTT-
TCTTGCTC-3 ,P R5  -CACTCAGCACTGGATGAGGA-
3 )( http://www.genome.wi.mit.edu/cgibin/primer/primer3
www.cgi). Genomic DNA from peripheral blood cells
was extracted using the QIAamp Blood Kit according to
the manufacturer’s instructions. PCR reaction was car-
ried out in 50μL of solution containing 100ng of ge-
nomic DNA, 0.5μmol/L of each primer, 200μmol/L of each
dNTP, 20mmol/L of TrisHCl (pH 8.5), 50mmol/L of KCl,
3mmol/L of MgCl2, and 1.0U of Taq polymerase (Qiagen).
The ampliﬁcation was performed on thermocycler (Perkin
Elmer 9600), with a predenaturing procedure for 4 minutes
at 94◦C for 35 cycles (denaturing at 94◦Cf o r1m i n u t e ,a n -
nealing at 60◦C for 1 minute, and extension at 72◦Cf o r1
minute), followed by an additional 10-minute incubation at
72◦C. PCR products were puriﬁed with QIAquick PCR Pu-
riﬁcation Kit (QIAGEN) and sequencing was performed by
using Amersham Dynamic ET Terminator Cycle Sequenc-
ing Kit and Perkin Elmer Big Dye Terminator Kit versus 3.1
with F&R primers in both directions and analyzed in ABI
310 sequencer. The MEFV ﬁrst exon sequences were aligned
and analyzed using Mutation Explorer (DEMO) version 2.41
software (Softgenetics Inc).
RESULTS
WehavecarriedoutMEFVpyrindomainmutationalanalysis
on54TurkishpatientswithBehc ¸et’sdisease.Aunique406bp
fragment successfully ampliﬁed by PCR for all 54 samples
was tested. This suggests that there were no detectable ge-
nomic deletions or insertions concerning pyrin domain of
MEFV gene (Figure 1). Same PCR products were puriﬁed
and used for direct sequencing to analyze single nucleotide
changes. These 54 samples were successfully sequenced and
no mutations in pyrin domain coding sequence and its im-
mediately ﬂanking sequences were observed (Figure 2).
DISCUSSION
Modular protein-protein interaction domains play an im-
portant role in many intracellular signal transduction path-
ways [14]. In inﬂammation and apoptosis signaling path-
ways,threemajorfamiliesofproteinmoduleshavebeenpro-
posed: the death domain (DD), the death eﬀector domain
(DED), and the caspase recruitment domain (CARD) [15].
These protein modules of approximately 100 amino acids in
length function to mediate homotypic protein-protein in-
teraction between signaling components leading to the ac-
tivation of speciﬁc downstream targets. They are all from
α-helical bundles acting as adapters in signaling pathways
and recruiting other proteins into signaling complexes [16].
These domains are required for the transmission and reg-
ulation of signals from receptor to eﬀector, such as cas-
pases,viahomotypicinteractionsinwhichDDsinteractwith
DDs, DEDs interact with DEDs, and CARDs interact with
CARDs [17]. Moreover, despite their low degree of sequence
similarity, these homotypic interaction domains have been
proved to share a common three-dimensional fold, classiﬁed
as death-domain fold [18].
At the time of the FMF susceptibility gene discovery,
the function of pyrin was unknown, however, a signiﬁ-
cant breakthrough occurred when pyrin was found to be a
member of the death fold superfamily [11, 19], with its N-
terminal pyrin domain (PYD) homologous to the death do-
main (DD), death eﬀector domain (DED), and caspase re-
cruitment domain (CARD) subfamilies. Pyrin protein has
an important role in both NF-kB transcription factor ac-
tivation and apoptosis, however, the exact details have not
been suﬃciently predictive. There is evidence that pyrin in-
hibits both NF-kB activation and apoptosis, induced by the
ASC (apoptosis-associated speck-like protein containing a
CARD) adaptor protein, by disruption of the interaction be-
tween ASC and caspase-8 [20].
Pyrin deﬁcient mice have a defect in apoptosis, suggest-
ing a proapoptotic role for pyrin through caspase recruit-
ment, and full-length pyrin competes in vitro with caspase-1
for binding to ASC, a known caspase-1 activator, thus in-
hibiting pro-IL-1b cytokine processing to the active form
[21].
Further insights into the function of pyrin have re-
cently been revealed by an unusual collusion of two exper-
iments of nature. Pyogenic arthritis, pyoderma gangreno-
sum, and acne (PAPA) syndrome are characterized by poly-
morphonuclear leukocyte invasion of joints and skin, pro-
ducing a destructive arthritis and skin lesions, which can be
extensive and disﬁguring in some cases. This disease is due
to mutations in the adaptor protein, praline serine threo-
ninephosphatase-interactingprotein1(PSTPIP1),whichisa
tyrosine-phosphorylated protein involved in cytoskeletal or-
ganization; these mutations result in altered binding of PST-
PIP1 to the PEST-type protein tyrosine phosphatase (PTP-
PEST, AAA36529) [22]. In a search for pyrin binding pro-
teins, Shoham et al studied cells from patients with PAPA
syndrome, and, by using a combination of techniques in-
cluding yeast two-hybrid assay: coimmunoprecipitation and
coimmunoﬂuorescence, have demonstrated an interaction
between pyrin and PSTPIP1 [23]. They have thus revealed a
biochemical pathway common to both FMF and PAPA syn-
dromes.Ahmet Dursun et al 3
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Figure 1: Diagram depicting the conserved domains of the human MEFV protein. Arrows indicate genomic localization of primers used for
pyrin domain ampliﬁcation.
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Figure 2: Representative results from 4 patients’ direct DNA se-
quencing of PCR product for MEFV gene pyrin domain and wild
type sequence of presented region.
PYRIN domain is also present in apoptosis-associated
speck-like protein (ASC) and target of methylation-induced
silencing1(TMS1),whichfunctionsasapositivemediatorof
apoptosis [11, 24]. Inﬂammation and apoptosis upregulate
ASC in neutrophils and, depending on the cellular context, it
can either inhibit or activate NF-kB [25]. ASC contains both
apyrinandaCARDdomain.ASCandpyrinseemtointeract
viatheirpyrindomains,whiletheCARDdomainofASCwas
shown to bind to the CARD domain of caspase-1 [24, 26].
The pyrin domain of ASC was further shown to bind to
POP1/ASC2, a small protein consisting of a single pyrin do-
main with a high level of amino-acid-sequence similarity
t ot h ep y r i nd o m a i no fA S C[ 27]. The interaction between
ASC and POP1/ASC2 results in a modulation of NF-kB and
procaspase-1 regulation [27]. Finally, there is evidence that
ASC and caspase-1, together with NALP1 (another PYRIN-
domain protein) and caspase-5, form a proapoptotic com-
plex, named inﬂammasome, which is essential for innate im-
munity involving LPS-induced apoptosis [28].
Apoptotic and inﬂammatory roles of the pyrin were fur-
ther demonstrated via caspase activation. The pyrin domain
has a role as adaptor between NALP3 (receptor) and caspase
1( e ﬀector) in NALP3 inﬂammasome production. This leads
to the cytokine activation and apoptosis [29].
Two further human hereditary diseases were recently at-
tributed to the pyrin-domain protein: Muckle-Wells syn-
drome and familial cold autoinﬂammatory syndrome [30].
Although pyrin domains occur in more than 20 human
proteins, only a few additional pyrin-domain proteins have
been characterized functionally. Almost all of them appear
to be involved in apoptosis and inﬂammation [31, 32].
There have been reports that pyrin mutations might not
be enough for clinical outcome for PAPA syndrome. Al-
though pyrin regulates the IL-1b pathway, it also inﬂuences
NF-kB activation and apoptosis, and therefore, even if the
interaction with pyrin is the most important one in PAPA,
there might be other pyrin-dependent eﬀects apart from the
regulation of IL-1 b activation [22].
To the best of our knowledge, no mutation analysis is
available for pyrin domain of the MEFV gene. Considering
that pyrin-domain proteins interact frequently with other
pyrin-domain proteins, pyrin-pyrin interactions are likely
an important feature of pyrin-domain function. In conclu-
sion, we have presented the results of pyrin-domain muta-
tion screening from 54 BD patients. Although, MEFV gene
mutations have been reported as the cause of BD, pyrin do-
main has not been mutated. On the other hand, our results
do not exclude the possibility that the MEFV gene is inacti-
vated by mutations located regions other than pyrin domain
or another molecular mechanism. Interaction between pyrin
domains needs to be further investigated, thus, pathophysi-
ological mechanisms of autoinﬂammatory diseases might be
explained.
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